Dr. de Conti is a staff fellow researcher in the U.S. Department of Health and Human Services at the National Center for Toxicological Research (NCTR) of the U.S. Food and Drug Administration (FDA). Dr. de Conti has knowledge in key areas for cancer research, specifically, in the field of elucidation of mechanism(s) by which dietary factors and other environmental exposures influence epigenetic processes that contributes for development of cancer.
Dr. de Conti received a graduate degree in Pharmacy from the Faculty of Pharmacy Oswaldo Cruz, and Ph.D. in Food Science, from the University of Sao Paulo, in Sao Paulo, Brazil. After this period Dr. de Conti moved to United States for a postdoctoral position at FDA-NCTR. In 2015, she was selected her to be a member of the NCTR research program to investigate the contribution of epigenetic changes to the process of cancer development. Dr. de Conti is author of 28 peer peer-reviewed articles.
The involvement of Dr. de Conti with the Hispanic Organization of Toxicologist (HOT) started in 2014 when she received the HOT Postdoctoral Travel Award. In the year 2015, Dr. de Conti was indicated as editor in-chief of Toxenlaces, the HOT bi-monthly newsletter. Within 1 year Dr. de Conti received the Outstanding Award as Toxenlaces editor. Moreover, Dr. de Conti has been actively involved in educational initiatives developed by HOT, such as, development of educational webinars and mentoring activities.‹ Return